Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Serina Therapeutics (SER) Assets Average (2019 - 2025)

Serina Therapeutics (SER) has disclosed Assets Average for 7 consecutive years, with $9.7 million as the latest value for Q4 2025.

  • Quarterly Assets Average rose 36.76% to $9.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.7 million through Dec 2025, up 36.76% year-over-year, with the annual reading at $6.8 million for FY2025, 12.85% down from the prior year.
  • Assets Average hit $9.7 million in Q4 2025 for Serina Therapeutics, down from $10.7 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $12.4 million in Q2 2023 to a low of $2.3 million in Q3 2022.
  • Historically, Assets Average has averaged $6.9 million across 5 years, with a median of $7.5 million in 2024.
  • Biggest five-year swings in Assets Average: crashed 44.55% in 2021 and later soared 433.83% in 2023.
  • Year by year, Assets Average stood at $2.8 million in 2021, then dropped by 5.95% to $2.6 million in 2022, then soared by 303.47% to $10.6 million in 2023, then plummeted by 33.14% to $7.1 million in 2024, then soared by 36.76% to $9.7 million in 2025.
  • Business Quant data shows Assets Average for SER at $9.7 million in Q4 2025, $10.7 million in Q3 2025, and $7.8 million in Q2 2025.